Q: Any comments on Axon, has had a pretty rough 6 months. It was pretty highly recommended is it still high on your list to recommend for future growth?
Q: Hello,
I thought Costco's results were good, yet stock is down. Any comments on the results which would bring the stock price down? Also, would vgg on tsx be a good way to invest in US dividend paying stocks. If not, can you suggest one in Canadian dollars please. Much appreciated. Happy Holidays.
Q: May I have your comments on DVAX? They seem to have strong earnings but is their outlook for 2026 negative? Please also comment on their cash flow, debt, dividend sustainability, share buyback, insider ownership and another aspects you feel are noteworthy. The stock charts red because it has declined 16% YTD. I do not own the stock. The stock seems to be too small to be a value trap but I am a little puzzled why it can’t seem to gain traction.
Thank you,
Jim
Q: Hello, I invested in the ETF BUG about a year ago. I had compared it to HACK and thought that BUG was more a pure play on cybersecurity than HACK, which has AVGO, NOC and GD as top 10 holdings (AVGO at #1 with 12%). After a year, BUG has barely moved whereas HACK has moved over 10%, probably because of the 3 stocks I mentioned. To what extend these 3 stocks belong in a cybersecurity ETF? If so, should I switch to HACK? Do you believe these 3 stocks will still perform very well in the years ahead? I have plenty of NVDA, so it was never my intention to buy AVGO on its own. Thanks.
I have held VRT for 2.5 years and done well and have a full position in it. It has drifted lower as AI waffles around and other AI related players get more attention.
Do you see VRT as a “must own” for the space or do you have another stock in this space with more momentum and growth potential?
Also, Would you endorse selling a half position of VRT to buy ENS?
Sending all you fine folks at 5i the warmest wishes for the holidays. Thank you for all of your guidance throughout the years. It is appreciated. Enjoy some time off!
5i reccommended TSAT in a recent portfolio update and is now approx $6 higher than when you recommended it. Moved nicely on the govt contract news etc. My question here is what would you reccommend to enter this stock. A) Buy it at market now, B) Average in 1/3 at a time C) Sell an April 30 put at approx $3.5? or D) just wait out the volatility and buy it at a stink price between 25 and 30?
Secondly on a Tom Lee podcast he waxed eloquent about SATS and told listeners that if they don't own it go and buy it. Doesn't do that often with individual stocks. What is your opinion of SATS, it has really come a long way too this year. Would you consider it a buy?
Q: Greetings 5i, I would like to revisit the investment thesis for Ilumina, sold it for a tax loss but the stock spiked up on earnings and has continued to rise. Please provide an analysis of its future prospects and your opinion as to whether or not this is a buy now. Or, is there a better option in this field? I already have a good sized position in Intuitive Surgical. Thank you.
Q: This equity appeared recently in my RRIF account…..I did not receive any information about a spin off from any of my holdings but maybe I wasn’t paying attention. I presume that’s where it came from. A Danish company I believe, listed on the NYSE. Can you enlighten me please.
Thanks for your service.
Len
Q: Hi 5i Guys,
I've noticed that NBIS has variously been top, mid and lower mid in your growth rankings for US stocks depending on the day. How are you feeling about its prospects these days - both for a 2 year, 5 year and 10 year horizon?
Thanks so much and hope you are all moving into great holidays soon!
J
Q: I am trying to reduce the number of stocks in my portfolio. I hold both these but in small quantities. No tax consequences. Any reason to keep or add to either ? Thoughts on one stock to consider for replacing them, please ?
Among the tech giants, I own NVDA, GOOG, and AMZN. I have a high level of confidence in NVDA and Google, but not the same level for AMZN. My reasoning for owning AMZN is its upside potential, I think, driven by operational efficiency improvements and advertising revenue growth, despite cloud competition. I belive MSFT has the most resilient business model for compounding with diversified revenue streams and a clear path to AI monetization. The case for AAPL is its business and ecosystem, and it is a potential winner if AI doesn’t pan out as expected.
All of them are buyable and ownable, and I would appreciate your input on which three stocks you are more confident in for a long-term hold and why.
1) What do you make of the recent numbers?
2) Would you buy it for a 3 year hold or will AI be nibbling away at it's breakfast, lunch and dinner?
3) If so, what sort of price would be attractive bearing in mind it seems to have pulled out of it's nose dive with a more positive 2 week chart?
Q: A month ago, in your answer to Ellen, you recommended MSTR as a replacement for IBIT for tax loss harvesting. Unfortunately, it turned out to be a bad advise, as MSTR dropped over 21% vs. IBIT drop of 11% since. You repeated the same recommendation in your answer to Lai Kuen 3 weeks ago, but this time you mentioned that MSTR's "NAV could erode further below 1X"... can you please explain why would NAV erode below 1X? It seems counterintuitive for the company with NAV tied to the Bitcoin price. I am aware of the risk of removal from Nasdaq, yet, it appears that MSTR is in a freefall these days.
What are your thoughts on Lululemon these days? After this year's move lower, tax-loss season (almost) behind us now, and news of the CEO announcing his departure yesterday, I am thinking of a small ADD. But only if 5i tells me it is OK to do so :)